Biltmore Family Office’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.11M Buy
37,284
+1,472
+4% +$327K 1.13% 12
2025
Q4
$8.18M Buy
35,812
+887
+3% +$202K 1.13% 12
2025
Q3
$8.09M Buy
34,925
+3,408
+11% +$694K 1.15% 12
2025
Q2
$5.85M Sell
31,517
-2,930
-9% -$545K 0.99% 16
2025
Q1
$7.22M Buy
34,447
+2,402
+7% +$467K 1.23% 11
2024
Q4
$5.69M Sell
32,045
-126
-0.4% -$23.2K 0.96% 18
2024
Q3
$6.35M Buy
32,171
+559
+2% +$104K 1.09% 11
2024
Q2
$5.42M Buy
31,612
+1,700
+6% +$282K 1% 13
2024
Q1
$5.45M Sell
29,912
-400
-1% -$68.9K 1.07% 13
2023
Q4
$4.7M Hold
30,312
0.97% 13
2023
Q3
$4.52M Hold
30,312
1.02% 13
2023
Q2
$4.08M Sell
30,312
-85
-0.3% -$12.5K 0.86% 17
2023
Q1
$4.84M Sell
30,397
-2,314
-7% -$354K 1.02% 14
2022
Q4
$5.29M Sell
32,711
-151
-0.5% -$23.2K 1.09% 10
2022
Q3
$4.41M Sell
32,862
-304
-0.9% -$43.6K 1.01% 11
2022
Q2
$5.08M Sell
33,166
-132
-0.4% -$20.2K 1.27% 10
2022
Q1
$5.4M Sell
33,298
-8,323
-20% -$1.21M 1.16% 9
2021
Q4
$5.63M Buy
41,621
+802
+2% +$94.7K 1.07% 12
2021
Q3
$4.4M Buy
40,819
+5,738
+16% +$656K 1.06% 14
2021
Q2
$3.95M Buy
35,081
+357
+1% +$40.2K 1.12% 11
2021
Q1
$3.76M Sell
34,724
-1,899
-5% -$203K 1.17% 13
2020
Q4
$3.92M Sell
36,623
-8,511
-19% -$818K 1.18% 12
2020
Q3
$3.95M Sell
45,134
-5,146
-10% -$484K 2.21% 10
2020
Q2
$4.94M Sell
50,280
-3,853
-7% -$339K 2.97% 7
2020
Q1
$4.12M Buy
54,133
+352
+0.7% +$30K 2.71% 8
2019
Q4
$4.76M Buy
53,781
+114
+0.2% +$9.46K 1.91% 11
2019
Q3
$4.06M Buy
53,667
+2,000
+4% +$137K 1.76% 13
2019
Q2
$3.76M Hold
51,667
2.03% 13
2019
Q1
$4.16M Hold
51,667
2.11% 10
2018
Q4
$4.76M Buy
51,667
+578
+1% +$50.8K 2.69% 6
2018
Q3
$4.83M Sell
51,089
-260
-0.5% -$24.7K 2.3% 9
2018
Q2
$4.76M Sell
51,349
-3,770
-7% -$368K 2.37% 11
2018
Q1
$5.22M Buy
55,119
+1,485
+3% +$163K 2.32% 7
2017
Q4
$5.19M Buy
+53,634
New +$5.05M 2.35% 7

Other funds holding ABBV